You can help stop Sepsis, says Pfizer Philippines on World Sepsis Day

Sepsis is a serious health threat that you might not have heard about. Sepsis develops when the body’s fight against an infection becomes so intense that it ends up damaging its own organs.1 It is a severe complication of infections that can possibly lead to permanent disability and even death.1 Almost all infections, including viral infections like COVID-19, can lead to sepsis.1 The 2020 Global Burden of Disease study showed that sepsis is involved in 1 out of every 5 deaths worldwide, and that it primarily affects young children in in low- to middle-income countries.2

We can stop sepsis if we all work together.1,2 We can do this by learning how to prevent infections and by making sure sepsis is identified early, so that patients can be treated with the right medication before it’s too late.1 On World Sepsis Day last September 13, Pfizer Philippines, in line with the Global Sepsis Alliance, helped to raise awareness on this condition. Since 2012, educators and leaders in the healthcare sector have banded together to spread the word on sepsis through numerous programs geared towards bringing sepsis to the public eye. World Sepsis Day is a time to help patients and caregivers by teaching them simple steps that we can all take to help stop sepsis.

Pfizer Philippines wants to help provide health for all Filipinos, especially the most vulnerable segments of the population. In addition to supporting campaigns that bring together healthcare providers, health care companies and organizations with the goal of improving the health knowledge of general public, Pfizer Philippines remains committed to advancing breakthroughs that change people’s lives, ensuring access to quality medicines and products that answer the Filipino’s ever-evolving needs, including antibiotics to help fight sepsis.

Ask your doctor about sepsis.

References: 

  1. World Sepsis Day 2020. Sepsis. Last access September 2020. Available at: https://www.worldsepsisday.org/sepsis
  2. Global Sepsis Alliance. The Lancet: Sepsis associated with 1 in 5 deaths worldwide, double prior estimates – children and poor regions hit hardest. Published January 16, 2020. Last access Septemebr 2020. Available at: https://www.global-sepsis-alliance.org/news/2020/1/16/the-lancet-sepsis-associated-with-1-in-5-deaths-worldwide-double-prior-estimates-children-and-poor-regions-hit-hardest-global-burden-disease-study-kristina-rudd
  3. Kumar, A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34(6):1589-1596. ;

https://journals.lww.com/ccmjournal/Abstract/2006/06000/Duration_of_hypotension_before_initiation_of.1.aspx

 

Pfizer, Inc.
18/F – 20/F, 8 Rockwell Building
Hidalgo Drive, Rockwell Center Poblacion

November 2020
PP-PFE-PHL-0086

 

About Pfizer: Breakthroughs That Change Patient’s Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more please visit us on www.Pfizer.com and follow us on twitter at @Pfizer and @Pfizer News, Linkedin, YouTube and like us on Facebook at Facebook.com/Pfizer.

ADVT.

Read more...